Weekly Journal Scan: In search of a sweet spot for prolonged dual antiplatelet therapy in patients with multivessel coronary artery disease
- 3 September 2026
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Extended Dual Antiplatelet Therapy for Multivessel Coronary Artery Disease.New England Journal of Medicine, 2026
- Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial InfarctionNew England Journal of Medicine, 2025
- Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsEuropean Heart Journal, 2022
- Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskNew England Journal of Medicine, 2021
- Complete Revascularization with Multivessel PCI for Myocardial InfarctionNew England Journal of Medicine, 2019
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIJAMA, 2019
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary InterventionJAMA, 2019
- Coronary Atherosclerotic Phenotype and Plaque Healing in Patients With Recurrent Acute Coronary Syndromes Compared With Patients With Long-term Clinical StabilityJAMA Cardiology, 2019
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial InfarctionNew England Journal of Medicine, 2015
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsNew England Journal of Medicine, 2014